Menu
Back to User profile » Dr Chaitanya Dutt
Papers published by Dr Chaitanya Dutt:
TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial
Joshi D, GJ P, Ghosh S, Mohanan A, Joshi S, Mohan V, Chowdhury S, Dutt C, Tandon N
Diabetes, Metabolic Syndrome and Obesity 2022, 15:615-631
Published Date: 25 February 2022
Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries
Dutt C, Nunes Salles JE, Joshi S, Nair T, Chowdhury S, Mithal A, Mohan V, Kasliwal R, Sharma S, Tijssen J, Tandon N
Diabetes, Metabolic Syndrome and Obesity 2022, 15:451-465
Published Date: 16 February 2022
Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis
Gupta R, Chaudhary AR, Shah BN, Jadhav AV, Zambad SP, Gupta RC, Deshpande S, Chauthaiwale V, Dutt C
Clinical and Experimental Gastroenterology 2014, 7:13-23
Published Date: 24 January 2014
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
Zambad SP, Tuli D, Mathur A, Ghalsasi SA, Chaudhary AR, Deshpande S, Gupta RC, Chauthaiwale V, Dutt C
Diabetes, Metabolic Syndrome and Obesity 2014, 7:1-14
Published Date: 21 December 2013
TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
Shitalkumar P Zambad, Siralee Munshi, Amita Dubey, et al
Diabetes, Metabolic Syndrome and Obesity 2011, 4:5-16
Published Date: 6 January 2011